Cargando…
A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia
OBJECTIVES: To compare the performance of a new blood test for colorectal cancer (CRC) to an established fecal immunochemical test (FIT) in a study population with the full range of neoplastic and non-neoplastic pathologies encountered in the colon and rectum. METHODS: Volunteers were asked to compl...
Autores principales: | Symonds, Erin L, Pedersen, Susanne K, Baker, Rohan T, Murray, David H, Gaur, Snigdha, Cole, Stephen R, Gopalsamy, Geetha, Mangira, Dileep, LaPointe, Lawrence C, Young, Graeme P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737873/ https://www.ncbi.nlm.nih.gov/pubmed/26765125 http://dx.doi.org/10.1038/ctg.2015.67 |
Ejemplares similares
-
Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia
por: Pedersen, Susanne K., et al.
Publicado: (2015) -
Detection of methylated
BCAT1
and
IKZF1
after curative‐intent treatment as a prognostic indicator for colorectal cancer recurrence
por: Pedersen, Susanne K., et al.
Publicado: (2022) -
Methylation and Gene Expression of BCAT1 and IKZF1 in Colorectal Cancer Tissues
por: Jedi, Maher, et al.
Publicado: (2018) -
A cross‐sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor‐derived DNA with CEA for detection of recurrent colorectal cancer
por: Young, Graeme P., et al.
Publicado: (2016) -
Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1
por: Symonds, Erin L., et al.
Publicado: (2022)